About Mangeet Kaur Bouns

Mangeet’s keen interest in the stock market led her to become an investment researcher and financial journalist. Using her fundamental approach to analyzing stocks, Mangeet’s looks to help retail investors understand the underlying factors before making investment decisions. She earned a bachelor's degree in finance from BI Norwegian Business School.

Recent Articles By Mangeet Kaur Bouns

: APA |  News, Ratings, and Charts

1 Energy Stock That Makes a Great Addition to Your Portfolio

Leading Oil & Gas company APA Corporation (APA) reported impressive second-quarter financials, and the stock has gained in double digits so far this year. The company is well-positioned to witness solid growth in the upcoming quarters, driven by its diversified portfolio, strategic acquisitions, and sustained energy demand. So, we think this energy stock makes a great addition to your portfolio. Continue reading…
: PSTG |  News, Ratings, and Charts

1 Stock to Store in Your Portfolio Right Now

IT pioneer Pure Storage (PSTG) delivered solid financial results in the second quarter of fiscal 2023, driven by an expanding portfolio of its industry-leading products and services. Moreover, analysts are bullish about the company’s near-term prospects. Given its diversified business, robust financials, high profitability, and solid growth prospects, it could be wise to add PSTG to your portfolio. Read on…
: SNAP |  News, Ratings, and Charts

3 Falling Stock to Think About Selling Short Right Now

Worries about sky-high inflation, the Federal Reserve’s hawkish stance, and recession prospects have spurred market sell-off lately. Moreover, investors expect increased market volatility as analysts cut down their earnings estimates. Given the uncertain market conditions, fundamentally weak and losing stocks Snap (SNAP), Allegiant Travel (ALGT), and Cardiff Oncology (CRDF) could be great candidates to sell short. Read on…
: NERV |  News, Ratings, and Charts

NERV Stock Is on the Move, but Is It a Buy?

Biopharmaceutical company Minerva Neurosciences (NERV) delivered considerable losses in its last quarter. Investors are increasingly concerned about the company’s massive debt burden and increased cash burn. Despite its limited earnings growth prospects, the stock has gained more than 260% over the past month because the company submitted an NDA for its schizophrenia therapy. So, is NERV a buy now? Continue reading to learn our view...
: DNA |  News, Ratings, and Charts

Cathie Wood Doubled Down on This Biotech Stock, Should You?

Biotech company Ginkgo Bioworks’ (DNA) top-line growth didn’t translate into bottom-line improvement in its last quarter. The stock is currently trading approximately 84% below its 52-week high, and analysts expect the company to report significant losses in the fiscal 2022 and 2023. However, since renowned investor Cathie Wood has recently doubled down on DNA, should you follow her action? Read on to find out…
: WEBR |  News, Ratings, and Charts

Stay as Far Away as Possible From This Meme Stock

Outdoor cooking company Weber (WEBR) reported deteriorating third-quarter financials. Moreover, the company has suspended its quarterly cash dividend and withdrawn its fiscal 2022 net sales and earnings outlook, as high consumer prices and other uncertainties are crushing in-store and online traffic and margins. While the stock witnessed a short squeeze-driven rally lately, we think it could be wise to stay away from this meme stock. Continue reading…
: SOFI |  News, Ratings, and Charts

Is SoFi Stock a Buy as Biden Forgives Student Loans?

Financial services company SoFi Technologies (SOFI) reported disappointing second-quarter financials, and the stock is currently trading more than 75% below its 52-week high. Furthermore, analysts are bearish about the company’s earnings growth prospects. However, given Biden’s announcement of student loan forgiveness and an end to the loan repayment pause, is it wise to buy SOFI now? Read on to find out…
: UNH |  News, Ratings, and Charts

3 Stocks to Prepare Your Portfolio for the Next Black Swan Event

Black swan events are world-changing events that are rare and unpredictable and have outcomes with devastating effects. These events have severe implications for financial markets and investment portfolios. While investors cannot predict a black swan event, it could be wise to prepare your portfolio by investing in high-quality stocks, such as UnitedHealth (UNH), Walmart (MT), and Lifeway Foods (LWAY). Continue reading…
: MSFT |  News, Ratings, and Charts

1 Stock That Continues to Outperform the S&P 500

Software giant Microsoft (MSFT) reported robust fourth-quarter financials. The company is well-positioned to capitalize on the continued transition of businesses to cloud platforms. The tech stock has outperformed the S&P 500 over the past five years. And in addition to market-beating price returns, MSFT has raised its dividend for 17 consecutive years. So, this stock is an excellent option for investors looking for a steady income and long-term capital appreciation. Read on…
: BFLY |  News, Ratings, and Charts

Cathie Wood Is Building up Her Stake in This Stock. Should You?

Digital health company Butterfly Network (BFLY) reported a year-over-year increase in revenue in the last quarter, but its bottom line declined significantly. Moreover, its near-term prospects look bleak as analysts expect the company’s loss to widen in the coming quarters. However, since Cathie wood has recently loaded up shares of BFLY, should investors follow the lead? Read more to find out…

Page generated in 0.8828 seconds.